Matador Resources to Sell 5 Million Shares

Matador Resources to Sell 5 Million Shares

Matador Resources Company, an independent energy company, started an underwritten public offering of 5 million shares of its common stock. Also on Monday, Matador said it seeks to offer $150 million of its 6.875% senior notes due 2023 in a private placement to eligible purchasers. The additional notes are being offered as additional notes to Matador’s existing $400 million of 6.875% senior notes due 2023 that Matador issued in a […]

Read More ˃
Asian ADRs Move Higher in Friday Trading

Asian ADRs Move Higher in Friday Trading

American depository receipts of Asian stocks were trading 0.41% higher at 143.12 on the Bank of New York Mellon Asia ADR Index on Friday. In North Asia, the gainers were led by bank holding company Mitsubishi UFJ Financial (MTU), and financial services firm Nomura (NMR), which rose 5.3% and 4.2% respectively. They followed by healthcare group Hutchison China Meditech (HCM), up 3.5%, and financial holding company Mizuho Financial (MFG), higher […]

Read More ˃
US Stocks Little Changed in Early Trading

US Stocks Little Changed in Early Trading

US stocks were little changed in early trading Friday after a mixed November jobs report. Employers added 178,000 jobs, beating expectations for a gain of 170,000, and the unemployment rate fell to 4.6% from 4.9% a month earlier, but the participation rate declined and wages fell, the Department of Labor said in a report. The Federal Reserve’s Federal Open Markets Committee is expected to raise its federal funds rate later […]

Read More ˃
Financial Stocks Largely on Positive Ground

Financial Stocks Largely on Positive Ground

Financial stocks were mostly higher this afternoon, with the NYSE Financial Sector Index rising over 0.5% while financial companies in the S&P 500 Index were adding nearly 1.3% in value. In company news, Fifth Street Finance (FSC) fell Wednesday after today saying Ivelin Dimitrov will step down as president and chief investment officer at the specialty finance company, effective Jan. 2. The company also said it has hired Patrick Dalton […]

Read More ˃
AstraZeneca’s Medimmune Collaborates With Abpro to Develop Antibody

AstraZeneca’s Medimmune Collaborates With Abpro to Develop Antibody

AstraZeneca’s biologics research and development arm Medimmune said Tuesday it is collaborating with the life sciences company Abpro to advance the development of a preclinical, novel bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor. The agreement is structured as a spin out, benefiting from both companies’ scientific expertise and Abpro’s day-to-day leadership as it oversees the new company, AbMed. Abpro will receive majority global development and commercialization rights to […]

Read More ˃